08/10/2022
07/28/2022
05/02/2022
04/29/2022
11/30/2021
11/22/2021
11/05/2021
Deciphera Pharmaceuticals Announces Top-Line Results from the INTRIGUE Phase 3 Clinical Study
08/10/2022
07/28/2022
05/02/2022
04/29/2022
11/30/2021
11/22/2021
11/05/2021
Deciphera Pharmaceuticals Announces Top-Line Results from the INTRIGUE Phase 3 Clinical Study